Analysis of Natural Killer Activity and Antibody-dependent Cellular Cytotoxicity in Healthy Volunteers and in Patients with Primary Lung Cancer and Metastatic Pulmonary Tumors

Overview

Journal J Cancer Res Clin Oncol

Specialty Oncology

Date 1982 Jan 1

PMID 7061569

Citations 7

Authors

N Saijo

E Shimizu

N Irimajiri

A Ozaki

K Kimura

T Takizawa

H Niitani

Affiliations

Soon will be listed here.

Abstract

To clarify the contribution of ADCC and NK activities to host immune response against cancer, the characteristics of cells mediating these activities were examined in the peripheral blood lymphocytes of normal volunteers, and the changes of these activities were also evaluated in patients with lung cancer and metastatic pulmonary tumors before and after chemotherapy. OAT cells derived from small cell carcinoma of the lung and K-562 cells derived from erythroleukemia were used as target cells of ADCC and/or NK assay. ADCC and NK activities were not changed according to age, sex, and blood type. Mild and marked personal difference were observed in ADCC and NK activity, respectively. These activities were also influenced by environment. ADCC and NK activities of normal adult volunteers were diversely correlated at the coefficient of gamma-0.426. NK activities were high against K-562 and CCRF-CEM cells, and low against BALL and OAT cells. NK activity against K-562 cells was strongly inhibited by K-562 or CCRF-CEM cells with high NK sensitivity, on the other hand, it was slightly inhibited by OAT and BALL cells with low NK sensitivity. NK activity against OAT cells was strongly inhibited by OAT, K-562 and CCRF-CEM cells, but not inhibited by BALL cells. The effector cells mediating NK activity were identified as non-adherent, E-receptor-positive, Fc-receptor-positive small lymphocytes. NK activity was not decreased before chemotherapy in patients with stage III primary lung cancer and metastatic pulmonary tumors. It was decreased only in patients of bad performance status, and it was significantly decreased in all patients after chemotherapy. ADCC also exhibited the tendency to decrease after chemotherapy in tumor-bearing patients. The recovery of NK-activity after chemotherapy well correlated with the effect of chemotherapy.

Citing Articles

Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents.

Saijo N, Ozaki A, Beppu Y, Takahashi K, Fujita J, Sasaki Y J Cancer Res Clin Oncol. 1984; 107(3):157-63.

PMID: 6736102 DOI: 10.1007/BF01032600.

The analysis of cytostatic activity of human peripheral blood granulocytes and its augmentation with Nocardia rubra cell wall skeleton (N-CWS).

Shimizu E, Saijo N, Shibuya M, Takizawa T, Hoshi A J Cancer Res Clin Oncol. 1983; 106(2):130-5.

PMID: 6630283 DOI: 10.1007/BF00395391.

Effect of chemotherapy on natural-killer activity and antibody-dependent cell-mediated cytotoxicity in carcinoma of the lung.

Saijo N, Shimizu E, Shibuya M, Irimajiri N, Takizawa T, Eguchi K Br J Cancer. 1982; 46(2):180-9.

PMID: 6185128 PMC: 2011091. DOI: 10.1038/bjc.1982.182.

Suppression of natural killer activity in patients treated with cisplatin and methylprednisolone.

Takahashi K, Saijo N, Kimata M, Sasaki Y, Fujita J, Futami H J Cancer Res Clin Oncol. 1985; 109(1):78-81.

PMID: 3919031 DOI: 10.1007/BF01884259.

In vivo augmentation of the cytotoxicity of spleen lymphocytes against syngeneic B-16 melanoma cells and the suppression of the artificial metastases in C57BL/6 mice by subcutaneous multiple injections of high dose human recombinant interleukin-2....

Saijo N, Ozaki A, Nakano H, Sakurai M, Takahashi H, Sasaki Y J Cancer Res Clin Oncol. 1986; 111(3):182-6.

PMID: 3488319 DOI: 10.1007/BF00389231.

References

Kleinerman E, Zwelling L, Muchmore A . Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II). Cancer Res. 1980; 40(9):3099-102. View

Ojo E, Haller O, Kimura A, Wigzell H . An analysis of conditions allowing Corynebacterium parvum to cause either augmentation or inhibition of natural killer cell activity against tumor cells in mice. Int J Cancer. 1978; 21(4):444-52. DOI: 10.1002/ijc.2910210408. View

Potter M, Moore M . Natural cytotoxic reactivity of human lymphocyte subpopulations. Immunology. 1979; 37(1):187-94. PMC: 1457286. View

Mukherji B, Flowers A, Rothman L, NATHANSON L . Spontaneous in vitro cytotoxicity against autochthonous human melanoma cells. J Immunol. 1980; 124(1):412-7. View

Ojo E . Positive correlation between the levels of natural killer cells and the in vivo resistance to syngeneic tumor transplants as influenced by various routes of administration of Corynebacterium parvum bacteria. Cell Immunol. 1979; 45(1):182-7. DOI: 10.1016/0008-8749(79)90374-5. View

Balch C, Ades E, Loken M, Shore S . Human "null" cells mediating antibody-dependent cellular cytotoxicity express T lymphocyte differentiation antigens. J Immunol. 1980; 124(4):1845-51. View

Riccardi C, Puccetti P, Santoni A, Herberman R . Rapid in vivo assay of mouse natural killer cell activity. J Natl Cancer Inst. 1979; 63(4):1041-5. View

Masucci M, Masucci G, Klein E, Berthold W . Target selectivity of interferon-induced human killer lymphocytes related to their Fc receptor expression. Proc Natl Acad Sci U S A. 1980; 77(6):3620-4. PMC: 349669. DOI: 10.1073/pnas.77.6.3620. View

Samlaska C . Linoleic acid inhibition of naturally occurring lymphocytotoxicity to breast cancer-derived cells measured by a chromium-51 release assay. J Natl Cancer Inst. 1979; 62(6):1427-33. View

10.

Takasugi M, Hardiwidjaja M, McAllister R, Peer M . Search for specificity in natural cell-mediated cytotoxicity. J Natl Cancer Inst. 1979; 63(6):1299-304. View

11.

Takasugi M, Akira D . Role of antibodies in the specificity of natural cell-mediated cytotoxicity. J Natl Cancer Inst. 1979; 62(6):1361-5. View

12.

Fujibayashi T, Sato O, Itoh H . Stage-related, cell-mediated cytotoxicity with effector cell analysis and computation of cytotoxic activity of T cells and non-T cells. Cell Immunol. 1979; 44(2):225-41. DOI: 10.1016/0008-8749(79)90001-7. View

13.

Eremin O, Ashby J, STEPHENS J . Human natural cytotoxicity in the blood and lymphoid organs of healthy donors and patients with malignant disease. Int J Cancer. 1978; 21(1):35-41. DOI: 10.1002/ijc.2910210108. View

14.

Miller R, Treves A, Kaplan H . Cytotoxic T-lymphocyte and spontaneous killer cell activity against human T- and B-lymphoid cell lines. Cell Immunol. 1979; 47(1):46-56. DOI: 10.1016/0008-8749(79)90313-7. View

15.

Gupta S, Fernandes G, Nair M, GOOD R . Spontaneous and antibody-dependent cell-mediated cytotoxicity by human T cell subpopulations. Proc Natl Acad Sci U S A. 1978; 75(10):5137-41. PMC: 336279. DOI: 10.1073/pnas.75.10.5137. View

16.

Santoni A, Herberman R, HOLDEN H . Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells. J Natl Cancer Inst. 1979; 63(4):995-1003. View

17.

Stanley K . Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst. 1980; 65(1):25-32. View

18.

Burton R, Grail D, Warner N . Natural cytotoxicity of haemopoietic cell populations against murine lymphoid tumours. Br J Cancer. 1978; 37(5):806-17. PMC: 2009622. DOI: 10.1038/bjc.1978.119. View

19.

Zarling J, Schlais J, Eskra L, GREENE J, Tso P, CARTER W . Augmentation of human natural killer cell activity by polyinosinic acid-polycytidylic acid and its nontoxic mismatched analogues. J Immunol. 1980; 124(4):1852-7. View

20.

Hersey P, Edwards A, Honeyman M, McCarthy W . Low natural-killer-cell activity in familial melanoma patients and their relatives. Br J Cancer. 1979; 40(1):113-22. PMC: 2009943. DOI: 10.1038/bjc.1979.147. View